Response Genetics Appoints Company President
This article was originally published in Scrip
Executive Summary
Los Angeles-based Response Genetics, a company developing and commercialising molecular diagnostic tests for cancer has appointed Christine Meda as the new company president. Ms Meda brings nearly 30 years of know-how in strategic partnering, operations, and marketing to her role at Response. She also founded and is still president of RxDxLink, a consultancy advising early stage biotechnology firms.